Inventor · disambiguated record
Xilin Zhou
Also filed as: ZHOU XILIN
3 granted patents·3 pending applications·1 citations·filing 2021–2025
52Inventor score
Files withNOVARTIS AG6
Top patents by PatentIndex Score
6 records- 0179US11919911B2Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carboxylate and methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as CAV1.2 activatorsNOVARTIS AG·Filed 2021·Granted Mar 5, 2024·1 cites·22 claims
- 0273US12365690B2Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyrodine-3-carboxylate as Cav1.2 activatorsNOVARTIS AG·Filed 2024·Granted Jul 22, 2025·0 cites·10 claims
- 0368US2025304594A1METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[B]PYRIDINE-3-CARBOXYLATE AND METHYL (R)-2-(FLUOROMETHYL)-5-OXO-4-PHENYL-1,4,5,7-TETRAHYDROFURO[3,4-B]PYRIDINE-3-CARBOXYLATE AS Cav1,2 ACTIVATORSNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0457US2025051345A1Pyridine-3-carboxylate compounds as cav1.2 activatorsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0555US11453679B2Methyl 2-methyl-5-oxo-1,4,5,7-tetradhydrofuro[3,4-b]pyridine-3-carboxylate compounds as Cav1.2 activatorsNOVARTIS AG·Filed 2021·Granted Sep 27, 2022·0 cites·17 claims
- 0654US2024182456A12-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesityNOVARTIS AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xilin Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →